Ancillary testing in lung cancer diagnosis

Area of Science:

• Oncology
• Pathology
• Molecular Diagnostics

Background:

• Historically, lung cancer diagnosis relied on tumor morphology in histologic sections.
• Emerging targeted therapies necessitate more than just accurate cancer typing.
• Pathologists increasingly provide prognostic and predictive information impacting patient management.

Purpose of the Study:

• To review current ancillary tests in lung cancer pathologic diagnosis.
• To highlight the role of immunohistochemistry and molecular diagnostics.
• To inform on tests influencing patient management strategies.

Main Methods:

• Literature review of ancillary diagnostic tests for lung cancer.
• Focus on immunohistochemistry techniques.
• Emphasis on molecular diagnostic methodologies.

Main Results:

• Ancillary tests are integral to modern lung cancer diagnosis.
• Immunohistochemistry aids in precise tumor subtyping.
• Molecular diagnostics identify targets for personalized medicine.

Conclusions:

• Ancillary tests are essential for comprehensive lung cancer diagnosis.
• Accurate prognostication and prediction are improved by these methods.
• Integration of these tests optimizes patient treatment pathways.